Literature DB >> 7678067

Fetal hemoglobin in acute and chronic states of erythroid expansion.

C A Blau1, P Constantoulakis, A al-Khatti, E Spadaccino, E Goldwasser, T Papayannopoulou, G Stamatoyannopoulos.   

Abstract

Physiologic principles underlying the differences in fetal hemoglobin (HbF) induction between acute and chronic states of erythroid expansion are poorly understood. Whereas abrupt erythroid expansion is characterized by a high proportion of reticulocytes coexpressing adult and fetal globin (F reticulocytes), HbF levels wane with chronic erythropoietic stimulation. To investigate this phenomenon, we used various schedules of erythropoietin (epo) administration in primates. Acute intravenous epo administration promoted a 2- to 10-fold preferential induction of F reticulocytes compared with total reticulocytes. Total reticulocyte and F reticulocyte production were significantly correlated (correlation coefficient .41 to .74). With chronic epo administration, preferential F reticulocyte production was lost, and there was no correlation between reticulocyte and F reticulocyte production (correlation coefficient -.03). The mean percentage of F reticulocytes did not change between acute and chronic schedules of epo administration. The subcutaneous route of high-dose (3,000 U/kg) epo administration was as effective as intravenous administration in the induction of HbF. Reticulocyte and F reticulocyte responses to increasing epo doses were found to be saturable. These results suggest that the kinetics rather than absolute levels of reticulocyte and F reticulocyte response form the basis for preferential F reticulocyte induction with acute erythropoietic stimulation, and they support the hypothesis that F reticulocytes arise from a relatively rapid pathway of erythroid maturation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678067

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

2.  Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex.

Authors:  Marco Gabbianelli; Ugo Testa; Ornella Morsilli; Elvira Pelosi; Ernestina Saulle; Eleonora Petrucci; Germana Castelli; Serena Giovinazzi; Gualtiero Mariani; Micol E Fiori; Giuseppina Bonanno; Adriana Massa; Carlo M Croce; Laura Fontana; Cesare Peschle
Journal:  Haematologica       Date:  2010-03-19       Impact factor: 9.941

3.  The hydroxyurea-induced small GTP-binding protein SAR modulates gamma-globin gene expression in human erythroid cells.

Authors:  Delia C Tang; Jianqiong Zhu; Wenli Liu; Kyung Chin; Jun Sun; Ling Chen; John A Hanover; Griffin P Rodgers
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

4.  Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.

Authors:  R Borba; C S P Lima; H Z W Grotto
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

5.  Hb S/β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.

Authors:  André R Belisário; Anna B Carneiro-Proietti; Ester Cerdeira Sabino; Aderson Araújo; Paula Loureiro; Cláudia Máximo; Miriam V Flor-Park; Daniela D O W Rodrigues; Mina Cintho Ozahata; Christopher McClure; Rosimere Afonso Mota; Isabel C Gomes Moura; Brian Custer; Shannon Kelly
Journal:  Hemoglobin       Date:  2020-03-16       Impact factor: 0.849

6.  Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity.

Authors:  Farzin Pourfarzad; Marieke von Lindern; Azita Azarkeivan; Jun Hou; Sima Kheradmand Kia; Fatemehsadat Esteghamat; Wilfred van Ijcken; Sjaak Philipsen; Hossein Najmabadi; Frank Grosveld
Journal:  Haematologica       Date:  2012-10-25       Impact factor: 9.941

7.  HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques.

Authors:  Matthew M Hsieh; N Seth Linde; Aisha Wynter; Mark Metzger; Carol Wong; Ingrid Langsetmo; Al Lin; Reginald Smith; Griffin P Rodgers; Robert E Donahue; Stephen J Klaus; John F Tisdale
Journal:  Blood       Date:  2007-06-08       Impact factor: 22.113

8.  Negative Epistasis between Sickle and Foetal Haemoglobin Suggests a Reduction in Protection against Malaria.

Authors:  Bruno P Mmbando; Josephine Mgaya; Sharon E Cox; Siana N Mtatiro; Deogratias Soka; Stella Rwezaula; Elineema Meda; Evarist Msaki; Robert W Snow; Neal Jeffries; Nancy L Geller; Julie Makani
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

9.  Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.

Authors:  Siana Nkya Mtatiro; Julie Makani; Bruno Mmbando; Swee Lay Thein; Stephan Menzel; Sharon E Cox
Journal:  Am J Hematol       Date:  2014-10-20       Impact factor: 10.047

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.